Table 5 Summary of treatments performed in each eye
From: Eales’ disease: epidemiology, diagnostic and therapeutic concepts
Treatment | |
Periocular corticosteroids | 100% |
Systemic corticosteroids | 38% |
Laser photocoagulation | 95% (33% + Vitrectomy) |
Vitrectomy + Laser endophotocoagulation | 33.3% |
FA guided Photocoagulation + anti VEGF | 28.3% |
FA guided photocoagulation | 30.0% |
Scleral buckle + Vitrectomy + Laser endophotocoagulation | 1.7% |
Scleral buckle + Cryoretinopexy + Post-op photocoagulation | 1.7% |
No treatment (NLP eyes) | 5.0% |
Macular Edema Management | |
Periocular Corticosteroids | 43.8% |
AntiVEGF | 56.2% Bevacizumab 43.7% Aflibercept 12.5% |
Intravitreal dexamethasone implant (Ozurdex) | Ozurdex 6.2% |